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Hyperpolarization by dissolution dynamic nuclear polarization (DNP) is a versatile technique to dramatically en-
hance the nuclear magnetic resonance (NMR) signal intensity of insensitive long-T1 nuclear spins such as
6Li. The
6Li longitudinal relaxation of lithium ions in aqueous solutions strongly depends on the concentration of paramag-
netic species, even if they are present in minute amounts. We herein demonstrate that blood oxygenation can be
readily detected by taking advantage of the 6Li signal enhancement provided by dissolution DNP, together with
the more than 10% decrease in 6Li longitudinal relaxation as a consequence of the presence of paramagnetic
deoxyhemoglobin. Copyright © 2015 John Wiley & Sons, Ltd.
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1. INTRODUCTION
Oxygen delivery and consumption correlate with the physiolog-
ical state of tissues and organs and affect their metabolism. Path-
ological situations are characterized by variations in oxygenation
levels (1,2), which may directly affect treatment and recovery
(3,4). Oxygen uptake can be measured by positron emission to-
mography (PET) imaging following the inhalation of 15O2. How-
ever, the short 15O half-life (2.1 min) limits its availability, as it
requires an onsite cyclotron, and the use of ionizing radiation re-
stricts the number of examinations per patient (5). Alternatively,
the stable 17O isotope can be used to probe oxygen metabolism
by magnetic resonance (MR). Unlike 15O PET, 17O MR offers the
advantage to selectively measure the metabolically generated
H2
17O without confounding signals from the 17O2 molecules
bound to hemoglobin. However, the low gyromagnetic ratio of
17O (5.77 MHz/T) and the short associated T2* relaxation time
(~2 ms) leads to low sensitivity (6). A different MR method for
mapping oxygenation level is based on the blood oxygenation
level dependent (BOLD) contrast, which relies on the effect of
paramagnetic deoxyhemoglobin on proton transverse relaxation
(7). Although BOLD MR imaging is mostly known in the context of
cognitive neuroscience as functional MRI, recent studies have
shown that it can be used to map hypoxic regions in tumors (8).
The major drawback of this T2*-weighted imaging approach lies
in the dependence of T2* on many parameters other than the
oxygen level, including magnetic ﬁeld inhomogeneities, water
diffusion, and the structure of the blood vessel network including
blood volume, which may represent confounding variables (9).
The recently developed dissolution dynamic nuclear polariza-
tion (DNP) technique enables hyperpolarizing nuclear spins of
molecules in solutions that can be injected into cell suspensions,
perfused organs, animals, or humans (10). The large signal
resulting from the dramatic increase in polarization allows detec-
tion in real time of the biodistribution and the metabolism of
molecules containing nuclear spins with long longitudinal relax-
ation times (11–13). Consequently, DNP-enhanced MR studies
have been so far mostly restricted to precursors with non-
protonated spin-½ nuclei such as 13C-labeled carbonyls or 15N-la-
beled quaternary amines. However, it has been shown that 6Li, a
spin-1 nucleus with an exceptionally small quadrupole moment
(Q < 8.5 kHz), can also be hyperpolarized using dissolution
DNP and that hyperpolarized 6Li can be detected in vivo in the
rat brain (14). The 6Li longitudinal relaxation time of Li+ ions
can be as long as 550 s when dissolved in deoxygenated deuter-
ated water (D2O) at room temperature (15).
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A recent study showed that, following the intraperitoneal admin-
istration of lithium to rodents, a large fraction of the Li+ ions incor-
porated into the brain is located in the intracellular compartment
(16). Hyperpolarized 6Li could therefore be an interesting contrast
medium for perfusion imaging with methods similar to those
proposed with hyperpolarized xenon (17) and hyperpolarized 13C
tert-butanol (18). More generally, the potential of hyperpolarized
6Li as contrast agent for molecular imaging is high because Li+ ions
can replace the ubiquitous and essential Na+ ions in many biolog-
ical systems. It was previously shown that the 6Li T1 of Li
+ ions in
solutions is remarkably sensitive to the presence of paramagnetic
species and that hyperpolarized 6Li could be used as a sensor for
trace amounts (<mM) of Gd-based MR contrast agents (14). The
aim of the present study was to detect the blood oxygenation level
in human and rat blood and plasma using hyperpolarized 6Li.
2. RESULTS
To determine the effect of hemoglobin oxygenation on the T1 of
6Li, we simultaneously measured the decay of the hyperpolarized
6Li signal in three separate tubes, two of them (Tubes 1 and 3)
containing either whole blood and deoxygenated blood, or
plasma and deoxygenated plasma, and the third one (Tube 2)
containing D2O (99.6% D) to obtain a reference relaxation mea-
surement (Fig. 1). To separate the signals originating from each
of the three tubes, one-dimensional projections (gradient echo)
were acquired following non-selective 10° ﬂip angle pulses ap-
plied every 20 s. Gradient strength was adjusted to maximize
the signal per voxel while avoiding overlap between the signals
originating from the three different tubes in the one-dimensional
projection. In all measurements, the persistent radical which is
necessary for the DNP process was scavenged with sodium ascor-
bate prior to the infusion of the hyperpolarized solution into the
tubes (19). The 6Li decay curves were obtained from each exper-
iment by plotting the magnitude of the signal corresponding to
each tube as a function of time (Fig. 2). The characteristic decay
constants were obtained by ﬁtting the curves with mono-
exponential functions. The longitudinal relaxation time T1 was de-
duced after correcting for the effect of the pulses on the signal
decay. The 6Li T1 values measured in blood and plasma samples
are presented in Table 1.
To evaluate the effect of the radical scavenger on 6Li T1, mea-
surements were made in thermally polarized 0.5 M 6LiCl aqueous
solutions (D2O, 99.6% D) with or without scavenger (Table 2). The
T1 in pure non-deoxygenated D2O (99.98 % D) was similar to the
previously reported value for deoxygenated D2O (15). Adding 20
mM of sodium ascorbate, in either its protonated or deuterated
form, led to a decrease in T1 of about 20%. Although the ex-
changeable protons of ascorbate increase the concentration of
protonated water molecules and therefore participate in increas-
ing the solvent-induced dipolar relaxation of 6Li (20), the fact
that the T1 was nearly identical when ascorbate was deuterated
shows that the most prominent relaxation mechanism induced
by the presence of ascorbate is rather due to a direct interaction
between Li+ ions and ascorbate (a complete analysis of the relax-
ation mechanism is however beyond the scope of the present
study). When performing hyperpolarized 6Li MR experiments, it
was observed that an ascorbate-to-radical ratio of 3 was
Figure 1. Left: schematic representation of the tube holder containing
the three 10 mm glass tubes labeled from 1 to 3 and the surrounding
40 mm inner diameter coils. Tube 2 has thicker walls and served as a ref-
erence to assess the relaxation time of each hyperpolarized 6Li+ solution.
Tubes 1 and 3 served for the relative measurements between whole and
deoxygenated blood or plasma. Right: cross section showing the ar-
rangement of the three tubes inside the tube holder.
Figure 2. Top: time evolution of the tomographic projection of the 6Li
signal measured following the simultaneous injection of hyperpolarized
6Li+ solution into all three tubes. Projections were acquired along the
horizontal axis perpendicular to the static ﬁeld using a 2.5 ms 6 G/cm
dephasing gradient and a 20 ms 1.5 G/cm acquisition gradient. Bottom:
integral of the projected 6Li signal measured in Tubes 1–3 as a function
of time.
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insufﬁcient to rapidly scavenge the 0.4 mM of nitroxyl radical
present in the ﬁnal solution, since a substantially shorter T1 was
recorded (Table 2). In a second series of experiments, performed
with a drastically lower radical concentration corresponding to
an ascorbate-to-radical ratio of 30 for an ascorbate concentration
of 0.45 mM, the contribution of nitroxyl radicals to the 6Li relax-
ation was effectively quenched and essentially negligible.
Two parameters were measured to assess the efﬁciency of the
deoxygenation procedure: the partial pressure of oxygen (PO2),
representative of the concentration of free oxygen gas dissolved
in the sample, as well as the oxygen saturation (SO2), indicating
the fraction of hemoglobin bound to oxygen. The relative de-
crease in PO2 following deoxygenation, namely ([PO2]
oxy 
[PO2]
deoxy)/[PO2]
oxy, was 5.2% in blood and 36% in plasma, and
a relative reduction of ([SO2]
oxy  [SO2]deoxy)/[SO2]oxy = 2% was
measured in blood (Table 3).
The relative change in 6Li longitudinal relaxation time follow-
ing deoxygenation, namely (T1
oxy  T1deoxy)/T1oxy, was computed
for each experiment (Fig. 3). We observed in all experiments that
the 6Li T1 is shorter in deoxygenated blood than in whole blood,
i.e. partially oxygenated blood, with a mean relative variation be-
tween 10 and 15%. Conversely, the observed 6Li T1 is longer in
deoxygenated plasma than in partially oxygenated plasma. To
conﬁrm these results at pharmacologically relevant lithium level
in anticipation of future in vivo studies, a series of experiment
was carried out in rat blood and plasma using deuterated phos-
phate buffer instead of D2O for dissolution. The same trend was
observed with a relative change of +10.5% in rat blood and
6.5% in the plasma following deoxygenation. In this second se-
ries of experiments, the standard deviation on the relative differ-
ences was signiﬁcantly lower (less than 10%).
3. DISCUSSION
The present study shows that hemoglobin oxygenation can be
monitored through its inﬂuence on the hyperpolarized 6Li longi-
tudinal relaxation time. We chose to add ascorbate in the
hyperpolarized 6Li solutions not only to reduce the detrimental
effect of the TEMPOL (4-hydroxy-2,2,6,6-tetramethylpiperidine-
1-oxyl) radicals on the relaxation and therefore increase the T1,
but also to improve the reproducibility of the experiments since
even slight changes in radical concentration can have a strong
effect on the long 6Li relaxation time. As was already observed
Table 2. Longitudinal relaxation time of 6Li in various aque-
ous solutions. The measurements were made on a 400 MHz
high-resolution MR system (Bruker BioSpin, Fällanden,
Switzerland) using a saturation recovery protocol
Sample composition 6Li T1 (s)
0.5 M 6LiCl in pure D2O 506 ± 10
0.5 M 6LiCl in D2O with 20 mM
deuterated sodium ascorbate
401 ± 5
0.5 M 6LiCl in D2O with 20 mM
sodium ascorbate
394 ± 5
Hyperpolarized 6LiCl solution (n = 6)
(130 mM 6Li in D2O containing
1.2 mM ascorbate and 0.4 mM TEMPOL)
261 ± 5
Hyperpolarized 6LiCl solution (n = 8)
(0.65 mM 6Li in deuterated
phosphate buffer containing 0.45 mM
ascorbate and 0.015 mM TEMPOL)
413 ± 15
Table 1. Mean 6Li longitudinal relaxation time measured in
human and rat samples displayed with their standard devia-
tion (SD) and relative standard deviation (RSD)
6Li T1
(s)
SD
(s)
RSD
(%)
Human samples (130 mM 6Li, n = 3)
Whole blood 177 31 17.5
Deoxygenated blood 157 28 17.8
Plasma 115 7 6.1
Deoxygenated plasma 135 10 7.4
Rat samples (130 mM 6Li, n = 3)
Whole blood 180 19 10.5
Deoxygenated blood 153 12 7.8
Plasma 103 7 6.8
Deoxygenated plasma 123 5 4.0
Rat samples (0.65 mM 6Li, n = 4)
Whole blood 161 2 1.2
Deoxygenated blood 144 2 1.4
Plasma 137 4 2.9
Deoxygenated plasma 146 5 3.4
Table 3. Results of the oxygen gas analysis in blood and
plasma samples. The measurements were made using a
COBAS® b 121 system (Roche Diagnostic, Mannheim,
Germany)
Samples (n = 3) PO2 (mm Hg) SD (mm Hg) RSD (%)
Whole blood 45.9 0.6 1.3
Deoxygenated blood 43.5 0.5 1.1
Plasma 121.7 1.2 1.0
Deoxygenated plasma 77.9 13.4 17.2
SO2 (%) SD (%) RSD (%)
Whole blood 76.9 0.3 0.4
Deoxygenated blood 75.4 0.7 0.9
Figure 3. Mean relative change in 6Li longitudinal relaxation time after
deoxygenation of blood and plasma in both human and rat samples.
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with hyperpolarized [1-13C]acetate (20), a relatively large
ascorbate-to-radical concentration ratio must be used to
completely quench the radicals within the short hyperpolarized
MR experiments. However, increasing the scavenger concentra-
tion above a certain threshold will also lead to increased relaxa-
tion induced by the presence of ascorbate molecules. A possible
way to avoid this issue would be to use radicals such as BDPA
(1,3-bisdiphenylene-2-phenylallyl), which can be easily ﬁltered
out since they precipitate in aqueous solutions (21).
Oxygenated hemoglobin being diamagnetic, it does not affect
the 6Li relaxation. By blowing argon gas on whole blood samples,
oxyhemoglobin was transformed into deoxyhemoglobin. The
shorter 6Li T1 observed in deoxygenated blood as compared with
non-deoxygenated blood was ascribed to paramagnetic
deoxyhemoglobin. The relative (T1
oxy T1deoxy)/T1oxy ratio in 6Li lon-
gitudinal relaxation time is therefore positive in blood samples
(Fig. 3). This effect is similar to the BOLD contrast which originates
from the change in proton T2* induced by the paramagnetic re-
laxation caused by the presence of deoxyhemoglobin. In con-
trast, in plasma, oxygen is present as molecular O2, which is
paramagnetic. Blowing argon removes O2, thereby reducing the
concentration of paramagnetic species from the plasma and
leading to increased 6Li T1 values. The relative (T1
oxy  T1deoxy)/
T1
oxy ratio is therefore negative in plasma (Fig. 3).
A non-negligible variability in the 6Li T1 values measured in
blood and plasma samples was observed, in particular in exper-
iments performed in the ﬁrst series of experiments (Table 1).
These variances were dramatically reduced in the second series
of experiments performed with pharmacological doses of lith-
ium, and substantially longer T1 values were recorded in the
plasma samples. These two observations led us to conclude once
more that a large scavenger-to-radical ratio is necessary to limit
the effect of the unavoidable slight variations in radical concen-
tration on T1 and, while in blood samples the contribution of
deoxyhemoglobin to the 6Li longitudinal relaxation is dominant,
the nitroxyl radicals seem to be a non-negligible relaxation
mechanism in plasma samples.
It also appears that the mean relative (T1
oxy  T1deoxy)/T1oxy ratio
measure in blood samples is rather similar in all experiments,
ranging from 10.5 to 15%, whereas it varies from 6.5 to
20.5% in the plasma samples. This can be explained by the
strikingly high variability in plasma PO2 following the deoxygen-
ation procedure even within the same series of experiments (see
Table 3). In addition, the blood and plasma samples used in the
second series were more diluted than in the ﬁrst series of exper-
iments following the injection of 400 μL of hyperpolarized 6Li in
1.5 mL of samples instead of 300 μL of hyperpolarized 6Li in 2 mL
samples (see the Experiment section). The oxygen concentration
was therefore expected to be higher in the ﬁrst series of experi-
ments, meaning that a stronger effect of plasma deoxygenation
could be expected.
When comparing the relative changes in T1 measured in the
second series of experiments with the results of the gas analyses,
it appears that a 2% variation in blood oxygen level translates
into a 10.5% change in 6Li T1, demonstrating the high sensitivity
of the proposed method. Note that a relative variation of 36% in
PO2 measured in plasma only corresponds to a 6.5% change in
T1, showing that the relaxation of
6Li is remarkably more sensi-
tive to the presence of deoxyhemoglobin than of molecular
oxygen.
In a medical context, the primary use of lithium salts is to treat
manic–depressive (bipolar) and depressive disorders (22,23). For
7Li MR studies in humans (24), they have been administrated at
doses up to 1200 mg/day, which led to serum concentration
between 0.3 and 1 mM (25), a range similar to the concentra-
tion obtained after infusion of hyperpolarized [1-13C]pyruvate
in the ﬁrst clinical study (26). We show that blood oxygenation
can be monitored through its inﬂuence on the hyperpolarized
6Li longitudinal relaxation time also when using pharmacologi-
cal lithium doses. The observed difference in T1 between whole
and deoxygenated blood could therefore be possibly used to
detect hemoglobin oxygenation level in vivo, and T1-weighted
6Li imaging could be considered to obtain oxygenation maps.
This would be a particularly interesting diagnostic tool for
assessing tumor oxygenation level, for instance prior to radi-
ation therapy. It must, however, be borne in mind that the
intracellular and extracellular 6Li T1 values might be substan-
tially different and the interpretation of the results could be
intricate.
4. EXPERIMENTAL
Fresh human venous blood samples were provided by healthy
volunteers. Rat venous blood samples were collected by bleed-
ing 10 male Sprague-Dawley rats (384 ± 40 g). Rats were anes-
thetized with 1.5% isoﬂurane in a 30% O2/70% N2O mixture. All
animal experiments were performed according to federal and lo-
cal ethical guidelines, and the protocols were approved by the
local regulatory body (Service de la consommation et des affaires
vétérinaires, Affaires vétérinaires, Canton de Vaud, Switzerland).
3 UI/mL of heparin (Drossapharm, Basel, Switzerland) was added
to each human and animal blood sample. Samples were kept re-
frigerated at 5 °C in 50 mL Falcon tubes and were used within
two days of blood withdrawal. Plasma was extracted from blood
samples following natural phase separation in tubes stored in a
vertical position at 5 °C.
MR measurements were carried out on an actively shielded
horizontal 9.4 T/31 cm animal scanner (Varian/Magnex, Palo Alto,
CA, USA) using a custom-designed 1H/6Li probe based on two
stacked 40 mm inner diameter coils (machined from a double-
sided printed circuit board) surrounding a cylindrical tube holder
(Plexiglass) containing three 10 mm diameter glass tubes, two
with thin 0.55 mm walls (513-1PS-7, Wilmad, Vineland, NJ, USA)
and one with 1.45 mm wall thickness (513-7PPH-7, Wilmad, Vine-
land, NJ, USA). The geometry of the tube holder was designed so
that the horizontal tomographic projection of each of the three
tubes is well separated from one another (Fig. 1). In all experi-
ments the tube holder was inserted inside the magnet bore prior
to each dissolution DNP experiment. Proton images were ac-
quired to position the tube holder at the magnet isocenter and
static ﬁeld inhomogeneities were corrected by manual shim-
ming. The deoxygenation process consisted in blowing argon
gas inside the glass tube containing either blood or plasma for
10 min, about 5 min prior to the dissolution experiment. Heavy
noble gas was preferred over nitrogen gas to prevent air from
reoxygenating the samples before and during MR acquisitions.
Each tube was then covered with a perforated plastic cap. A
polytetraﬂuoroethylene (PTFE) capillary was inserted through
the cap to remotely inject the hyperpolarized 6Li+ solution into
the sample.
A ﬁrst series of experiments was performed in both human
and rat blood using a 6Li+ concentration of 130 mM. A set of
three 2 mL samples each inserted in one glass tube was probed:
R. BALZAN ET AL.
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Tube 1 and Tube 3 contained either whole blood and deoxygen-
ated blood or plasma and deoxygenated plasma. Tube 2 was ﬁlled
with pure D2O and served as a reference to assess the relaxation
time of each hyperpolarized 6Li+ solution. Prior to each experi-
ment, 350 μL of 15M 6LiCl solution prepared in 2:1 D2O/d6-ethanol
(v/v) dopedwith 40mM TEMPOLwas inserted, in the form of 2mm
diameter frozen beads, inside a custom-designed 7 T polarizer (27).
50 μL of frozen 1M aqueous sodium ascorbate solution was added
inside the sample cup to scavenge the TEMPOL radicals during the
dissolution process (19). All chemicals were purchased from Sigma-
Aldrich (Buchs, Switzerland). After 1 h of polarization at 1 ± 0.05 K,
the samples were rapidly dissolved in 5 mL of superheated D2O
(180 °C) and the resulting hyperpolarized 6Li+ solution was col-
lected out of the polarizer by blowing high-pressure helium gas
(6 bar) for 3.5 s through the dissolution insert previously described
(28). 300 μL of solution wasmanually and sequentially injected into
each 10 mm tube through a PTFE capillary within 10 s. Data acqui-
sition started 20 s after dissolution. The liquid-state 6Li polarization
at the time of measurements was estimated to be 5 ± 0.3% from a
comparison between the hyperpolarized and the thermally polar-
ized 6Li signals.
To conﬁrm these observations at pharmacologically relevant
Li+ level, a second series of experiments was performed in rat
blood and plasma. For these experiments, Tube 1 and Tube 3
were ﬁlled with 1.5 mL of either whole blood and deoxygenated
blood or plasma and deoxygenated plasma. Tube 2 was ﬁlled
with 1.5 mL of pure D2O. An amount of 5 μL of 3 M
6LiCl frozen
solution prepared in 1:1 D2O/glycerol-d8 (w/w) doped with 58
mM TEMPOL was inserted inside the polarizer along with 10 μL
of frozen 1 M aqueous sodium ascorbate solution. The concen-
tration of lithium salt was reduced from 15 M to 3 M to avoid in-
accuracy in sample volume when preparing the frozen beads.
Polarization time was set to 1.5 h and the samples were dis-
solved in 5 mL of superheated deuterated phosphate buffer.
The liquid-state 6Li polarization was 7.4 ± 0.5%. After having col-
lected the hyperpolarized 6Li+ solution, 400 μL of solution was
manually and sequentially injected prior to data acquisition.
The other parameters were identical to the ones set in the ﬁrst
series of experiments.
In conjunction with the hyperpolarized 6Li MR experiments,
oxygen gas analysis was performed in samples prepared in the
exact same way than those used in the second series of experi-
ments. For these analyses, 100 μL aliquots of blood or plasma
were taken from each sample and the PO2 and SO2 values were
obtained using a COBAS® b 121 system (Roche Diagnostic,
Mannheim, Germany).
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